All Stories

  1. Transformation of the tobacco product market in Japan, 2011–2023
  2. Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of adults in the PATH Study in 2017–2019 vs 2019–2021
  3. Impact of tobacco retail licensing on youth smoking in Virginia: A system dynamics simulation approach
  4. The Public Health Impact of a Ban on Flavored Cigars: A Decision-Theoretic Policy Framework
  5. Evaluating trends in cigarette and HTP use in Japan and measurement issues in the National Health and Nutrition Survey
  6. The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review
  7. The impact of removing a ban on electronic nicotine delivery systems using the Mexico smoking and vaping model (SAVM)
  8. Cross-state Border Nicotine Vaping Products Purchase – Early Evidence from State Emergency Sales Restrictions in 2019
  9. How do users compare the costs between nicotine vaping products and cigarettes? Findings from the 2016–2020 International Tobacco Control United States surveys
  10. Cigarette Prices and Disparities in Cessation in the United States
  11. The smoking and vaping model, A user-friendly model for examining the country-specific impact of nicotine VAPING product use: application to Germany
  12. Modeling the future of tobacco control: Using SimSmoke to explore the feasibility of the tobacco endgame in Korea
  13. Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model
  14. Potential Implications for Tobacco Industry Transformation of the Acquisition of Swedish Match by Philip Morris International
  15. The longitudinal association between coupon receipt and established cigarette smoking initiation among young adults in USA
  16. Are the Relevant Risk Factors Being Adequately Captured in Empirical Studies of Smoking Initiation? A Machine Learning Analysis Based on the Population Assessment of Tobacco and Health Study
  17. Birth Cohort‒Specific Smoking Patterns by Family Income in the U.S.
  18. Patterns of Birth Cohort‒Specific Smoking Histories by Race and Ethnicity in the U.S.
  19. Patterns of Birth Cohort‒Specific Smoking Histories in Brazil
  20. Summary and Concluding Remarks: Patterns of Birth Cohort‒Specific Smoking Histories
  21. Time-varying association between cigarette and ENDS use on incident hypertension among US adults: a prospective longitudinal study
  22. Using the Past to Understand the Future of U.S. and Global Smoking Disparities: A Birth Cohort Perspective
  23. Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015–2017 vs 2017–2019
  24. Cigarettes, ENDS Use, and Chronic Obstructive Pulmonary Disease Incidence: A Prospective Longitudinal Study
  25. Do Tobacco Companies Have an Incentive to Promote “Harm Reduction” Products?: The Role of Competition
  26. Chemical Profiles and Toxicity of Electronic Cigarettes: An Umbrella Review and Methodological Considerations
  27. An exploration of flavours in studies of e‐cigarettes for smoking cessation: secondary analyses of a systematic review with meta‐analyses
  28. The Longitudinal Association Between Cigarette Coupon Receipt and Short-term Smoking Cessation Among US Adults
  29. Do Current Smokers and Ex-Smokers Who Use Nicotine Vaping Products Daily Versus Weekly Differ on Their Reasons for Vaping? Findings from the 2020 ITC Four Country Smoking and Vaping Survey
  30. A Decision-Theoretic Public Health Framework for Heated Tobacco and Nicotine Vaping Products
  31. Associations Between E-cigarette Use and E-cigarette Flavors With Cigarette Smoking Quit Attempts and Quit Success: Evidence From a U.S. Large, Nationally Representative 2018–2019 Survey
  32. Impact of vaping restrictions in public places on smoking and vaping in the United States—evidence using a difference‐in‐differences approach
  33. The Australia Smoking and Vaping Model: The Potential Impact of Increasing Access to Nicotine Vaping Products
  34. Longitudinal Associations Between Exclusive and Dual Use of Electronic Nicotine Delivery Systems and Cigarettes and Self-Reported Incident Diagnosed Cardiovascular Disease Among Adults
  35. Health Effects of Electronic Cigarettes: An Umbrella Review and Methodological Considerations
  36. Public health impact of a US menthol cigarette ban on the non-Hispanic black population: a simulation study
  37. An analysis of cigarette sales during Poland’s menthol cigarette sales ban: small effects with large policy implications
  38. The Impact of Current Tobacco Product Use Definitions on Estimates of Transitions Between Cigarette and ENDS Use
  39. Impact of Canada’s menthol cigarette ban on quitting among menthol smokers: pooled analysis of pre–post evaluation from the ITC Project and the Ontario Menthol Ban Study and projections of impact in the USA
  40. Follow the money: a closer look at US tobacco industry marketing expenditures
  41. Trends in Exclusive, Dual and Polytobacco Use among U.S. Adults, 2014–2019: Results from Two Nationally Representative Surveys
  42. Poland is not replicating the HTP experience in Japan: a cautionary note
  43. Cigarette Pack Price and Its Within-Person Association With Smoking Initiation, Smoking Progression, and Disparities among Young Adults
  44. A longitudinal analysis of smoke‐free laws and smoking initiation disparities among young adults in the United States
  45. Public health impact of a US ban on menthol in cigarettes and cigars: a simulation study
  46. Tobacco retail availability and cigarette and e-cigarette use among youth and adults: a scoping review
  47. Sociodemographic Patterns of Exclusive and Dual Use of ENDS and Menthol/Non-Menthol Cigarettes among US Youth (Ages 15–17) Using Two Nationally Representative Surveys (2013–2017)
  48. Response to Braillon (2021): No, not the exception
  49. The Mexico SimSmoke tobacco control policy model: Development of a simulation model of daily and nondaily cigarette smoking
  50. An Expert Elicitation on the Effects of a Ban on Menthol Cigarettes and Cigars in the United States
  51. US Nicotine Vaping Product SimSmoke Simulation Model: The Effect of Vaping and Tobacco Control Policies on Smoking Prevalence and Smoking-Attributable Deaths
  52. Public health implications of vaping in the USA: the smoking and vaping simulation model
  53. Public Health Implications of Vaping in The US: The Smoking and Vaping Simulation Model
  54. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study
  55. An Analysis of the Altria-Juul Labs Deal: Antitrust and Population Health Implications
  56. E-cigarettes and Cessation: Asking Different Questions Requires Different Methods
  57. Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1–4): multistate transition modelling accounting for complex survey design
  58. The Kentucky SimSmoke Tobacco Control Policy Model of Smokeless Tobacco and Cigarette Use
  59. England SimSmoke: the impact of nicotine vaping on smoking prevalence and smoking‐attributable deaths in England
  60. Patterns of E-cigarette Use and Subsequent Cigarette Smoking Cessation Over 2 Years (2013/2014–2015/2016) in the Population Assessment of Tobacco and Health Study
  61. The actual and anticipated effects of a menthol cigarette ban: a scoping review
  62. The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes
  63. Support for Minimum Legal Sales Age Laws Set to Age 21 Across Australia, Canada, England, and United States: Findings From the 2018 ITC Four Country Smoking and Vaping Survey
  64. Public Health Implications of Vaping in the US: The Smoking and Vaping Simulation Model
  65. Taxation reduces smoking but may not reduce smoking disparities in youth
  66. Vaping popularity did not increase smoking rate
  67. Costs of vaping: evidence from ITC Four Country Smoking and Vaping Survey
  68. Smoking trends in Mexico, 2002–2016: before and after the ratification of the WHO’s Framework Convention on Tobacco Control
  69. Tobacco 21 Laws in Europe: A Policy Whose Time Has Come
  70. The Minnesota SimSmoke Tobacco Control Policy Model of Smokeless Tobacco and Cigarette Use
  71. Altria-Juul Labs deal: why did it occur and what does it mean for the US nicotine delivery product market
  72. Impact of nations meeting the MPOWER targets between 2014 and 2016: an update
  73. The US SimSmoke tobacco control policy model of smokeless tobacco and cigarette use
  74. The need for a comprehensive framework
  75. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products